These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20354264)

  • 1. [Gemini surfactants as gene carriers].
    Piskorska T; Obłak E
    Postepy Hig Med Dosw (Online); 2010 Mar; 64():161-6. PubMed ID: 20354264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New serine-derived gemini surfactants as gene delivery systems.
    Cardoso AM; Morais CM; Cruz AR; Silva SG; do Vale ML; Marques EF; de Lima MC; Jurado AS
    Eur J Pharm Biopharm; 2015 Jan; 89():347-56. PubMed ID: 25513958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between DNA and Gemini surfactant: impact on gene therapy: part I.
    Ahmed T; Kamel AO; Wettig SD
    Nanomedicine (Lond); 2016 Feb; 11(3):289-306. PubMed ID: 26785905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural, biocomplexation and gene delivery properties of hydroxyethylated gemini surfactants with varied spacer length.
    Zakharova LY; Gabdrakhmanov DR; Ibragimova AR; Vasilieva EA; Nizameev IR; Kadirov MK; Ermakova EA; Gogoleva NE; Faizullin DA; Pokrovsky AG; Korobeynikov VA; Cheresiz SV; Zuev YF
    Colloids Surf B Biointerfaces; 2016 Apr; 140():269-277. PubMed ID: 26764110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemini surfactants: a new family of building blocks for non-viral gene delivery systems.
    Wettig SD; Verrall RE; Foldvari M
    Curr Gene Ther; 2008 Feb; 8(1):9-23. PubMed ID: 18336246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bis-quaternary gemini surfactants as components of nonviral gene delivery systems: a comprehensive study from physicochemical properties to membrane interactions.
    Cardoso AM; Morais CM; Silva SG; Marques EF; de Lima MC; Jurado MA
    Int J Pharm; 2014 Oct; 474(1-2):57-69. PubMed ID: 25111434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-Delivery Ability of New Hydrogenated and Partially Fluorinated
    Massa M; Rivara M; Donofrio G; Cristofolini L; Peracchia E; Compari C; Bacciottini F; Orsi D; Franceschi V; Fisicaro E
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of novel gemini surfactants containing cycloalkyl side-chains on the structural phases of DNA in solution.
    Pietralik Z; Kumita JR; Dobson CM; Kozak M
    Colloids Surf B Biointerfaces; 2015 Jul; 131():83-92. PubMed ID: 25969417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemini surfactants mediate efficient mitochondrial gene delivery and expression.
    Cardoso AM; Morais CM; Cruz AR; Cardoso AL; Silva SG; do Vale ML; Marques EF; Pedroso de Lima MC; Jurado AS
    Mol Pharm; 2015 Mar; 12(3):716-30. PubMed ID: 25634573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cellular uptake and intracellular trafficking as determining factors of gene expression for amino acid-substituted gemini surfactant-based DNA nanoparticles.
    Singh J; Michel D; Chitanda JM; Verrall RE; Badea I
    J Nanobiotechnology; 2012 Feb; 10():7. PubMed ID: 22296763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and transfection properties of amine-substituted gemini surfactant-based nanoparticles.
    Wettig SD; Badea I; Donkuru M; Verrall RE; Foldvari M
    J Gene Med; 2007 Aug; 9(8):649-58. PubMed ID: 17654656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamic and aggregation properties of aza- and imino-substituted gemini surfactants designed for gene delivery.
    Wettig SD; Wang C; Verrall RE; Foldvari M
    Phys Chem Chem Phys; 2007 Feb; 9(7):871-7. PubMed ID: 17287881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Uptake and Distribution of Gemini Surfactant Nanoparticles Used as Gene Delivery Agents.
    Jin W; Al-Dulaymi M; Badea I; Leary SC; Rehman J; El-Aneed A
    AAPS J; 2019 Aug; 21(5):98. PubMed ID: 31388860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and aggregation properties of dissymmetric phytanyl-gemini surfactants for use as improved DNA transfection vectors.
    Wang H; Wettig SD
    Phys Chem Chem Phys; 2011 Jan; 13(2):637-42. PubMed ID: 20981388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing nonviral gene delivery: lipid- and surfactant-based nanoparticle design strategies.
    Donkuru M; Badea I; Wettig S; Verrall R; Elsabahy M; Foldvari M
    Nanomedicine (Lond); 2010 Sep; 5(7):1103-27. PubMed ID: 20874024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Engineering as an Approach To Modulate Gene Delivery Efficiency of Peptide-Modified Gemini Surfactants.
    Al-Dulaymi M; Michel D; Chitanda JM; El-Aneed A; Verrall RE; Grochulski P; Badea I
    Bioconjug Chem; 2018 Oct; 29(10):3293-3308. PubMed ID: 30169953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Di-Peptide-Modified Gemini Surfactants as Gene Delivery Vectors: Exploring the Role of the Alkyl Tail in Their Physicochemical Behavior and Biological Activity.
    Al-Dulaymi MA; Chitanda JM; Mohammed-Saeid W; Araghi HY; Verrall RE; Grochulski P; Badea I
    AAPS J; 2016 Sep; 18(5):1168-1181. PubMed ID: 27184577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A flow cytometric approach to study the mechanism of gene delivery to cells by gemini-lipid nanoparticles: an implication for cell membrane nanoporation.
    Gharagozloo M; Rafiee A; Chen DW; Foldvari M
    J Nanobiotechnology; 2015 Sep; 13():62. PubMed ID: 26415935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo cutaneous interferon-gamma gene delivery using novel dicationic (gemini) surfactant-plasmid complexes.
    Badea I; Verrall R; Baca-Estrada M; Tikoo S; Rosenberg A; Kumar P; Foldvari M
    J Gene Med; 2005 Sep; 7(9):1200-14. PubMed ID: 15895387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dicationic Amino Substituted Gemini Surfactants and their Nanoplexes: Improved Synthesis and Characterization of Transfection Efficiency and Corneal Penetration In Vitro.
    Narsineni L; Foldvari M
    Pharm Res; 2020 Jul; 37(7):144. PubMed ID: 32666411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.